Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fosfomycin disodium by Meitheal Pharmaceuticals for Pyelonephritis: Likelihood of Approval
Fosfomycin disodium is under clinical development by Meitheal Pharmaceuticals and currently in Pre-Registration for Pyelonephritis. According to GlobalData, Pre-Registration drugs...
Fosfomycin disodium by Meitheal Pharmaceuticals for Urinary Tract Infections: Likelihood of Approval
Fosfomycin disodium is under clinical development by Meitheal Pharmaceuticals and currently in Pre-Registration for Urinary Tract Infections. According to GlobalData,...
Denosumab biosimilar by Meitheal Pharmaceuticals for Bone Metastasis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Meitheal Pharmaceuticals and currently in Phase I for Bone Metastasis. According to GlobalData,...